Companies /Healthcare

Eterna Therapeutics Inc

NASDAQ: ERNA Biotechnology

$3.99

▼ $0.09 (−2.21%) today

Markets open · 1:01pm ET

Today · % change

Fundamentals

Market Cap

$4.8M

Revenue (TTM)

$1,000

EPS (TTM)

$-0.41

52-Week Range

$3 – $48

Street Target

$30.00

About Ernexa Therapeutics

Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.

ERNA Coverage

10:35am ET

Investing

Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners

President Trump’s 12-word remark, “I don’t think about Americans’ financial situation, I don’t think about anybody,” hit the wires, and the reaction showed up in the forgotten corners of the market, where…

ERNA HCWB MRNO

Alex Sirois